The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyN.K. Aaronson, Fumikazu Takeda, Sam H. Ahmedzai et al.|JNCI Journal of the National Cancer Institute|1993Cited by 15.9k
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.I. F. Tannock, K C Murphy, Peter Venner et al.|Journal of Clinical Oncology|1996Cited by 1.6k
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice GuidelinesRichard J. Gralla, David G. Pfister, David Osoba et al.|Journal of Clinical Oncology|1999Cited by 670
Recommendations on health-related quality of life research to support labeling and promotional claims in the United StatesDennis A. Revicki, Margaret Rothman, David Osoba et al.|Quality of Life Research|2000Cited by 575